Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 152 institutions that hold shares in the stock, with a total of 66.6 Million shares, which have been reported (via 13F filing form) to have a value of $268 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
10,109,279
shares
|
$42 Million
3.99% of portfolio
|
Q2 2023
Added 20.25%
|
|
|
Medicxi Ventures Management (Jersey) LTD
|
Apr 11, 2025 Q1 2025 |
7,464,572
shares
|
$31 Million
12.73% of portfolio
|
Q1 2024
Added 98.48%
|
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
7,042,325
shares
|
$29.2 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.29%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
3,650,812
shares
|
$15.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.56%
|
|
|
Carlyle Group Inc.
Washington, DC |
May 09, 2025 Q1 2025 |
3,496,808
shares
|
$14.5 Million
27.15% of portfolio
|
Q2 2023
Added 19.14%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,926,373
shares
|
$12.1 Million
0.0% of portfolio
|
Q2 2024
Added 6.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,778,687
shares
|
$11.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.03%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
2,514,284
shares
|
$10.4 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.51%
|
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
1,960,169
shares
|
$8.13 Million
1.17% of portfolio
|
Q4 2023
Added 53.55%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
May 15, 2025 Q1 2025 |
1,701,627
shares
|
$7.06 Million
0.06% of portfolio
|
Q1 2025
Added 9.15%
|
|
|
683 Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,445,000
shares
|
$6 Million
0.73% of portfolio
|
Q1 2025
Added 40.98%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
1,435,106
shares
|
$5.96 Million
5.34% of portfolio
|
Q1 2022
Added 19.28%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,200,000
shares
|
$4.98 Million
0.49% of portfolio
|
Q1 2025
Added 140.0%
|
|
|
Catalys Pacific, LLC
Tokyo, M0 |
May 14, 2025 Q1 2025 |
1,167,114
shares
|
$4.84 Million
4.92% of portfolio
|
Q4 2024
Added 3.97%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
1,134,927
shares
|
$4.71 Million
8.27% of portfolio
|
Q1 2025
Added 14.65%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,131,032
shares
|
$4.69 Million
0.0% of portfolio
|
Q1 2025
Added 17.04%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 05, 2025 Q1 2025 |
1,104,308
shares
|
$4.58 Million
0.06% of portfolio
|
Q1 2025
Added 0.14%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,016,423
shares
|
$4.22 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.2%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
901,354
shares
|
$3.74 Million
0.0% of portfolio
|
Q1 2025
Reduced 13.33%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
850,000
shares
|
$3.53 Million
4.88% of portfolio
|
Q2 2023
New holding
|
|
|
Avidity Partners Management LP
Dallas, TX |
May 15, 2025 Q1 2025 |
800,000
shares
|
$3.32 Million
1.13% of portfolio
|
Q1 2025
Reduced 42.45%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
751,692
shares
|
$3.12 Million
0.03% of portfolio
|
Q1 2025
Reduced 24.96%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
707,578
shares
|
$2.94 Million
0.0% of portfolio
|
Q1 2025
Added 51.97%
|
|
|
Simplify Asset Management Inc.
New York, NY |
May 13, 2025 Q1 2025 |
681,935
shares
|
$2.83 Million
0.17% of portfolio
|
Q1 2025
Added 17.18%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
596,108
shares
|
$2.47 Million
0.02% of portfolio
|
Q1 2025
New holding
|